Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.
Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
BJS Open. 2020 Jun;4(3):456-466. doi: 10.1002/bjs5.50280. Epub 2020 Apr 11.
Although total tumour volume (TTV) may have prognostic value for hepatic resection in certain solid cancers, its importance in colorectal liver metastases (CRLM) remains unexplored. This study investigated its prognostic value in patients with resectable CRLM.
This was a retrospective review of patients who underwent hepatic resection for CRLM between 2008 and 2017 in a single institution. TTV was measured from CT images using three-dimensional construction software; cut-off values were determined using receiver operating characteristic (ROC) curve analyses. Potential prognostic factors, overall survival (OS) and recurrence-free survival (RFS) were determined using multivariable and Kaplan-Meier analyses.
Some 94 patients were included. TTV cut-off values for OS and RFS were 100 and 10 ml respectively. Right colonic primary tumours, primary lymph node metastasis and bilobar liver metastasis were included in the multivariable analysis of OS; a TTV of 100 ml or above was independently associated with poorer OS (hazard ratio (HR) 6·34, 95 per cent c.i. 2·08 to 17·90; P = 0·002). Right colonic primary tumours and primary lymph node metastasis were included in the RFS analysis; a TTV of 10 ml or more independently predicted poorer RFS (HR 1·90, 1·12 to 3·57; P = 0·017). The 5-year OS rate for a TTV of 100 ml or more was 41 per cent, compared with 67 per cent for a TTV below 100 ml (P = 0·006). Corresponding RFS rates with TTV of 10 ml or more, or less than 10 ml, were 14 and 58 per cent respectively (P = 0·009). A TTV of at least 100 ml conferred a higher rate of unresectable initial recurrences (12 of 15, 80 per cent) after initial hepatic resection.
TTV was associated with RFS and OS after initial hepatic resection for CRLM; TTV of 100 ml or above was associated with a higher rate of unresectable recurrence.
尽管肿瘤总体体积(TTV)在某些实体瘤的肝切除中可能具有预后价值,但它在结直肠癌肝转移(CRLM)中的重要性仍未得到探索。本研究旨在探讨 TTV 在可切除 CRLM 患者中的预后价值。
这是一项对 2008 年至 2017 年间在一家单中心接受肝切除术治疗 CRLM 的患者进行的回顾性研究。使用三维构建软件从 CT 图像上测量 TTV;使用受试者工作特征(ROC)曲线分析确定截断值。使用多变量和 Kaplan-Meier 分析确定潜在的预后因素、总生存期(OS)和无复发生存期(RFS)。
共纳入 94 例患者。OS 和 RFS 的 TTV 截断值分别为 100 和 10ml。右半结肠癌原发灶、原发淋巴结转移和双侧肝转移被纳入 OS 的多变量分析;TTV 为 100ml 或以上与较差的 OS 独立相关(风险比(HR)6.34,95%置信区间(CI)为 2.08 至 17.90;P=0.002)。右半结肠癌原发灶和原发淋巴结转移被纳入 RFS 分析;TTV 为 10ml 或以上与较差的 RFS 独立相关(HR 1.90,1.12 至 3.57;P=0.017)。TTV 为 100ml 或以上的患者 5 年 OS 率为 41%,而 TTV 低于 100ml 的患者为 67%(P=0.006)。TTV 为 10ml 或以上或低于 10ml 的患者相应的 RFS 率分别为 14%和 58%(P=0.009)。初始肝切除后,TTV 至少为 100ml 与初始不可切除复发性(15 例中有 12 例,80%)的发生率较高相关。
TTV 与初始肝切除治疗 CRLM 后的 RFS 和 OS 相关;TTV 为 100ml 或以上与较高的不可切除复发率相关。